Major linear antibody epitopes and capsid proteins differentially induce protective immunity against Theiler's virus-induced demyelinating disease

Theiler's murine encephalomyelitis virus-induced immunologically mediated demyelinating disease (TMEV-IDD) in susceptible mice provides a relevant infectious model for multiple sclerosis. Previously, we have identified six major linear antibody epitopes on the viral capsid proteins. In this study, we utilized fusion proteins containing individual capsid proteins and synthetic peptides containing the linear antibody epitopes to determine the potential role of antibody response in the course of virus-induced demyelination. Preimmunization of susceptible mice with VPI and VP2 fusion proteins, but not VP3, resulted in the protection from subsequent development of TMEV-IDD. Mice free of clinical symptoms following preimmunizations with fusion proteins displayed high levels of antibodies to the capsid proteins corresponding to the immunogens. In contrast, the level of antibodies to a particular linear epitope, A1C (VP1(262-276)), capable of efficiently neutralizing virus in vitro increased with the progression of disease. Further immunization with synthetic peptides containing individual antibody epitopes indicated that antibodies to the epitopes are differentially effective in protecting from virus-induced demyelination. Taken together, these results suggest that antibodies to only certain linear epitopes are protective and such protection may be restricted during the early stages of viral infection.

[1]  J. Mikszta,et al.  Conversion of low antibody responders into high responders by up-regulating the T cell response to a selective epitope. , 1996, Journal of immunology.

[2]  R. Yauch,et al.  Identification of a major T-cell epitope within VP3 amino acid residues 24 to 37 of Theiler's virus in demyelination-susceptible SJL/J mice , 1995, Journal of virology.

[3]  S. Pincus,et al.  Protective efficacy of nonneutralizing monoclonal antibodies in acute infection with murine leukemia virus , 1995, Journal of virology.

[4]  S. H. Park,et al.  Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease. , 1995, Journal of immunology.

[5]  J. Escribano,et al.  A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice. , 1995, Virology.

[6]  M. G. Mateu,et al.  Antibody recognition of picornaviruses and escape from neutralization: a structural view. , 1995, Virus research.

[7]  R. Fujinami,et al.  B-lymphocyte requirement for vaccine-mediated protection from Theiler's murine encephalomyelitis virus-induced central nervous system disease , 1995, Journal of virology.

[8]  A. Nash,et al.  Lymphocyte recognition elements on the VP1 protein of Theiler's virus. , 1995, Immunology.

[9]  A. Nash,et al.  Lymphocyte recognition of picornaviruses. , 1995, The Journal of general virology.

[10]  R. Yauch,et al.  A predominant viral epitope recognized by T cells from the periphery and demyelinating lesions of SJL/J mice infected with Theiler's virus is located within VP1(233-244). , 1994, Journal of immunology.

[11]  Y. Choe,et al.  Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus , 1994, Journal of Neuroimmunology.

[12]  J. Peterson,et al.  Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice. , 1994, Journal of immunology.

[13]  S. Miller,et al.  Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope. , 1994, Journal of immunology.

[14]  R. Yauch,et al.  Effect of immunization with Theiler's virus on the course of demyelinating disease , 1993, Journal of Neuroimmunology.

[15]  C. Snapper,et al.  Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells , 1993, The Journal of experimental medicine.

[16]  I. Allen,et al.  Pathogenesis of Multiple Sclerosis—The Immune Diathesis and the Role of Viruses , 1993, Journal of neuropathology and experimental neurology.

[17]  C. Rupprecht,et al.  Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Luo,et al.  Three-dimensional structure of Theiler murine encephalomyelitis virus (BeAn strain). , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Filman,et al.  Three-dimensional structure of Theiler virus. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Y. Choe,et al.  Identification and localization of a limited number of predominant conformation-independent antibody epitopes of Theiler's murine encephalomyelitus virus. , 1992, Immunology letters.

[21]  M. D. Dal Canto,et al.  Hierarchy of effects of the MHC and T cell receptor beta-chain genes in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. , 1991, Journal of immunology.

[22]  T. Crawford,et al.  Antibody-mediated clearance of alphavirus infection from neurons. , 1991, Science.

[23]  A. Coutinho,et al.  Role of the humoral immune response in resistance to Theiler's virus infection , 1991, Journal of virology.

[24]  M. Francis,et al.  Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus. , 1991, Immunology.

[25]  J. Hogle,et al.  Neutralizing antibody to Mengo virus, induced by synthetic peptides. , 1991, The Journal of general virology.

[26]  G. Kaplan,et al.  Protection conferred by TrpE fusion proteins containing portions of the C-terminal region of capsid protein VP1 of foot-and-mouth disease virus. , 1991, The Journal of general virology.

[27]  F. Tangy,et al.  Genetic mapping of the ability of Theiler's virus to persist and demyelinate , 1990, Journal of virology.

[28]  R. Fujinami,et al.  Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler's murine encephalomyelitis virus , 1989, The Journal of experimental medicine.

[29]  M. Routbort,et al.  Theiler's murine encephalomyelitis virus neutralization escape mutants have a change in disease phenotype , 1989, Journal of virology.

[30]  M. Brahic,et al.  Characterization of B lymphocytes present in the demyelinating lesions induced by Theiler's virus. , 1989, Journal of immunology.

[31]  R. Fujinami,et al.  Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody , 1989, Journal of virology.

[32]  R. Roos,et al.  Trypsin-sensitive neutralization site on VP1 of Theiler's murine encephalomyelitis viruses , 1988, Journal of virology.

[33]  R. Roos,et al.  Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. , 1988, Virology.

[34]  W. Blakemore,et al.  The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. , 1987, The Journal of general virology.

[35]  H. Lipton,et al.  Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses , 1987, Journal of virology.

[36]  R. Knobler,et al.  Variations in genetic control of susceptibility to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Differences between susceptible SJL/J and resistant BALB/c strains map near the T cell beta-chain constant gene on chromosome 6. , 1987, Journal of immunology.

[37]  L. Steinman,et al.  Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice: critical importance of timing of treatment , 1987, Journal of virology.

[38]  H. Faden,et al.  Poliovirus vaccines: live or dead. , 1986, The Journal of pediatrics.

[39]  S. Miller,et al.  Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. , 1986, Journal of immunology.

[40]  S. Nitayaphan,et al.  Localization of a neutralization site of Theiler's murine encephalomyelitis viruses , 1985, Journal of virology.

[41]  M. Rodriguez,et al.  Demyelination induced by Theiler's virus: influence of the H-2 haplotype. , 1985, Journal of immunology.

[42]  D. Baltimore,et al.  Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[43]  H. Lipton,et al.  Theiler's virus antigen detected in mouse spinal cord 2½ years after infection , 1984, Neurology.

[44]  H. Lipton,et al.  Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice. , 1984, Journal of immunology.

[45]  H. Snippe,et al.  Neutralizing and non-neutralizing monoclonal antibodies to the E2 glycoprotein of Semliki Forest virus can protect mice from lethal encephalitis. , 1983, The Journal of general virology.

[46]  Richard A. Houghten,et al.  Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence , 1982, Nature.

[47]  Y. Lorch,et al.  Theiler's murine encephalomyelitis virus group includes two distinct genetic subgroups that differ pathologically and biologically , 1981, Journal of virology.

[48]  H. Lipton,et al.  Purification of Theiler's Murine Encephalomyelitis Virus and Analysis of the Structural Virion Polypeptides: Correlation of the Polypeptide Profile with Virulence , 1980, Journal of virology.

[49]  D. Madden,et al.  Protective effect of immune serum globulin (ISG) against hepatitis A infection in a natural epidemic. , 1977, American journal of epidemiology.

[50]  H. Lipton,et al.  Primary demyelination in Theiler's virus infection. An ultrastructural study. , 1975, Laboratory investigation; a journal of technical methods and pathology.

[51]  H. Lipton.  Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination , 1975, Infection and immunity.

[52]  E. Engvall,et al.  Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. , 1971, Immunochemistry.

[53]  M. Theiler,et al.  ENCEPHALOMYELITIS OF MICE : III. EPIDEMIOLOGY. , 1940 .

[54]  M. Theiler,et al.  ENCEPHALOMYELITIS OF MICE , 1940, The Journal of experimental medicine.

[55]  J. Peterson,et al.  IgG subclass responses to Theiler's murine encephalomyelitis virus infection and immunization suggest a dominant role for Th1 cells in susceptible mouse strains. , 1992, Immunology.

[56]  G. Woloschak,et al.  Theiler's virus-induced demyelination in mice immunosuppressed with anti-IgM and in mice expressing the xid gene. , 1990, Microbial pathogenesis.

[57]  R. Coffman,et al.  Lymphokine control of in vivo immunoglobulin isotype selection. , 1990, Annual review of immunology.

[58]  J. Mussini,et al.  [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.